Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 17, 2023

SELL
$154.35 - $166.11 $55,257 - $59,467
-358 Reduced 21.15%
1,335 $220,000
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $10,875 - $12,978
-72 Reduced 4.08%
1,693 $262,000
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $20,986 - $23,552
131 Added 8.02%
1,765 $311,000
Q3 2022

Nov 07, 2022

BUY
$161.33 - $179.52 $263,613 - $293,335
1,634 New
1,634 $267,000
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $190,559 - $210,749
-1,133 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $85,553 - $97,158
-541 Reduced 32.32%
1,133 $201,000
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $261,026 - $289,618
1,674 New
1,674 $286,000
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $1.89 Million - $2.09 Million
-11,672 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $25,516 - $27,371
160 Added 1.39%
11,672 $1.92 Million
Q1 2021

May 05, 2021

BUY
$153.07 - $170.48 $1.76 Million - $1.96 Million
11,512 New
11,512 $1.89 Million
Q2 2020

Jul 24, 2020

SELL
$128.81 - $155.51 $984,494 - $1.19 Million
-7,643 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$111.14 - $153.99 $680,732 - $943,188
6,125 Added 403.49%
7,643 $1 Million
Q4 2019

Jan 31, 2020

BUY
$127.5 - $146.44 $193,545 - $222,295
1,518 New
1,518 $221,000
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $239,808 - $268,502
-1,889 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$131.15 - $144.24 $99,805 - $109,766
-761 Reduced 28.72%
1,889 $263,000
Q1 2019

Apr 25, 2019

BUY
$125.72 - $139.79 $30,298 - $33,689
241 Added 10.0%
2,650 $370,000
Q4 2018

Jan 23, 2019

SELL
$122.84 - $147.84 $20,391 - $24,541
-166 Reduced 6.45%
2,409 $311,000
Q3 2018

Oct 31, 2018

BUY
$121.58 - $142.88 $119,756 - $140,736
985 Added 61.95%
2,575 $356,000
Q4 2017

Feb 07, 2018

SELL
$131.22 - $143.62 $119,935 - $131,268
-914 Reduced 36.5%
1,590 $222,000
Q3 2017

Nov 15, 2017

BUY
$129.47 - $135.38 $324,192 - $338,991
2,504
2,504 $326,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Camarda Financial Advisors, LLC Portfolio

Follow Camarda Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camarda Financial Advisors, LLC with notifications on news.